Table 3.

Body weight during administration period (mean ± SD, n = 10).

Groups	Body weight/g
	0 day	7 days	14 days	21 days	28 days	35 days
NCG	36.1 ± 0.7	39.7 ± 1.0	39.2 ± 0.9	40.9 ± 0.9	41.2 ± 0.9	43.5 ± 1.0
DG	32.2 ± 0.9##	34.3 ± 3.0#	31.7 ± 1.2#	35.2 ± 3.1##	36.3 ± 1.0##	37.6 ± 1.4##
HDG	31.8 ± 0.9	29.1 ± 2.5	29.5 ± 0.9	30.9 ± 2.9**	31.3 ± 1.2*	33.3 ± 1.1
MDG	31.5 ± 0.7	31.1 ± 2.5	29.3 ± 0.8	32.5 ± 2.6	33.0 ± 1.0	34.9 ± 1.0
LDG	31.5 ± 1.0	31.5 ± 0.9	30.5 ± 1.1	33.1 ± 0.8	33.9 ± 1.1	34.8 ± 1.2
MG	30.9 ± 0.6	30.5 ± 3.2	32.5 ± 0.9	33.0 ± 2.8	33.4 ± 1.0	34.9 ± 1.1
AG	31.8 ± 0.7	33.3 ± 2.6	31.3 ± 0.8	34.1 ± 2.7	35.2 ± 0.8	36.5 ± 1.0

^#P < 0.05, ^##P < 0.01 vs normal control group (NCG), *P < 0.05, ^**P < 0.01 vs diabetic group (DG).